Lindbrook Capital, LLC Spectrum Pharmaceuticals Inc Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	BUY	$0.63 - $1.59 $0 - $1	1 New	1 $0
Q3 2021 Nov 05, 2021	SELL	$2.15 - $3.82 $1,343 - $2,387	-625 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$2.89 - $4.45 $823 - $1,268	285 Added 83.82%	625 $2,000
Q1 2021 Apr 28, 2021	SELL	$2.9 - $4.09 $1,299 - $1,832	-448 Reduced 56.85%	340 $1,000
Q3 2020 Nov 03, 2020	BUY	$2.99 - $4.9 $1,339 - $2,195	448 Added 131.76%	788 $3,000
Q2 2020 Jul 27, 2020	BUY	$2.11 - $3.38 $717 - $1,149	340 New	340 $1,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.